ImmuCell Corporation Capital Expenditure, Discontinued Operations
ImmuCell Corporation (ICCC) reported Capital Expenditure, Discontinued Operations of $446.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes
us-gaap:CapitalExpenditureDiscontinuedOperations · last filed 2023-11-13
- ImmuCell Corporation capital expenditure, discontinued operations for the quarter ending 2023-09-30 was $78.00K, a 83.72% decline year-over-year.
- ImmuCell Corporation capital expenditure, discontinued operations for the quarter ending 2023-06-30 was $14.00K.
- ImmuCell Corporation capital expenditure, discontinued operations for the quarter ending 2023-03-31 was $354.00K, a 71.01% increase year-over-year.
- ImmuCell Corporation capital expenditure, discontinued operations for the quarter ending 2022-12-31 was -$453.00K, a 881.03% decline year-over-year.
- ImmuCell Corporation capital expenditure, discontinued operations for fiscal 2022 was $134.00K, a 15.52% increase from fiscal 2021.
- ImmuCell Corporation capital expenditure, discontinued operations for fiscal 2021 was $116.00K, a 5.69% decline from fiscal 2020.
- ImmuCell Corporation capital expenditure, discontinued operations for fiscal 2020 was $123.00K.
| Period end | Capital Expenditure, Discontinued Operations 3 month | Capital Expenditure, Discontinued Operations 6 month | Capital Expenditure, Discontinued Operations 9 month | Capital Expenditure, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2023-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $92.00K derived: sum of 2 quarters · filed 2023-11-13 | $446.00K 10-Q · filed 2023-11-13 | -$7.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $368.00K 10-Q · filed 2023-08-10 | -$85.00K derived: sum of 3 quarters · filed 2023-08-10 | $394.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $354.00K 10-Q · filed 2023-05-11 | -$99.00K derived: sum of 2 quarters · filed 2023-05-11 | $380.00K derived: sum of 3 quarters · filed 2023-05-11 | $281.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | -$453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $26.00K derived: sum of 2 quarters · filed 2023-03-29 | -$73.00K derived: sum of 3 quarters · filed 2023-03-29 | $134.00K 10-K · filed 2023-03-29 |
| 2022-09-30 | $479.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $380.00K derived: sum of 2 quarters · filed 2022-11-21 | $587.00K 10-Q · filed 2022-11-21 | $645.00K derived: sum of 4 quarters · filed 2022-11-21 |
| 2022-06-30 | -$99.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $108.00K 10-Q/A · filed 2022-11-21 | $166.00K derived: sum of 3 quarters · filed 2022-11-21 | $129.00K derived: sum of 4 quarters · filed 2022-11-21 |
| 2022-03-31 | $207.00K 10-Q/A · filed 2022-11-21 | $265.00K derived: sum of 2 quarters · filed 2022-11-21 | $228.00K derived: sum of 3 quarters · filed 2022-11-21 | $270.00K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $21.00K derived: sum of 2 quarters · filed 2022-03-30 | $63.00K derived: sum of 3 quarters · filed 2022-03-30 | $116.00K 10-K · filed 2022-03-30 |
| 2021-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $5.00K derived: sum of 2 quarters · filed 2021-11-15 | $58.00K 10-Q · filed 2021-11-15 | $5.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $95.00K 10-Q · filed 2021-08-12 | $42.00K derived: sum of 3 quarters · filed 2021-08-12 | $75.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $53.00K 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | $33.00K derived: sum of 3 quarters · filed 2021-05-13 | $140.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$20.00K derived: sum of 2 quarters · filed 2021-03-30 | $87.00K derived: sum of 3 quarters · filed 2021-03-30 | $123.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $140.00K derived: sum of 2 quarters · filed 2020-11-12 | $176.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $143.00K 10-Q · filed 2020-08-12 | ||
| 2020-03-31 | $36.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |